Dato: 24. april 2012
Årets meddelelse nr.: 6
Bestyrelsen for Blue Vision A/S har 24. april 2012 behandlet og godkendt delårsrapporten for perioden 1. januar – 31. marts 2012.
Dato: 24. april 2012
Årets meddelelse nr.: 6
Bestyrelsen for Blue Vision A/S har 24. april 2012 behandlet og godkendt delårsrapporten for perioden 1. januar – 31. marts 2012.
12 June 2026 Announcement no. 8 Pharma Equity Group prevails in international arbitration proceedings and is awarded EUR 10.5 million excluding interest and costs Pharma Equity Group A/S ("PEG" or...
Read MorePharma Equity Group’s subsidiary Reponex takes key step forward in Inflammatory Bowel Disease with upcoming European patent grant May 11, 2026Announcement no. 7 Pharma Equity Group A/S today...
Read More